Growth Metrics

Biohaven (BHVN) Enterprise Value (2022 - 2026)

Biohaven has reported Enterprise Value over the past 6 years, most recently at -$347.8 million for Q1 2026.

  • Quarterly results put Enterprise Value at -$347.8 million for Q1 2026, down 7.77% from a year ago — trailing twelve months through Mar 2026 was -$347.8 million (down 7.77% YoY), and the annual figure for FY2025 was -$319.1 million, up 34.33%.
  • Enterprise Value reached -$347.8 million in Q1 2026 per BHVN's latest filing, down from -$319.1 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$23.2 million in Q2 2022 and bottomed at -$486.0 million in Q4 2024.
  • Median Enterprise Value over the past 5 years was -$322.7 million (2025), compared with a mean of -$295.2 million.
  • Peak annual rise in Enterprise Value hit 85.99% in 2022, while the deepest fall reached 2798.06% in 2022.
  • Over 5 years, Enterprise Value stood at -$465.3 million in 2022, then rose by 17.95% to -$381.8 million in 2023, then dropped by 27.28% to -$486.0 million in 2024, then soared by 34.33% to -$319.1 million in 2025, then decreased by 8.99% to -$347.8 million in 2026.
  • Business Quant data shows Enterprise Value for BHVN at -$347.8 million in Q1 2026, -$319.1 million in Q4 2025, and -$260.2 million in Q3 2025.